• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBV 特异性 CD4 T 细胞的 TNF-α/IFN-γ 谱与慢性 HBV 感染中的肝损伤和病毒清除相关。

TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.

机构信息

Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing 400038, China.

出版信息

J Hepatol. 2020 Jan;72(1):45-56. doi: 10.1016/j.jhep.2019.08.024. Epub 2019 Sep 6.

DOI:10.1016/j.jhep.2019.08.024
PMID:31499130
Abstract

BACKGROUND & AIMS: The role of hepatitis B virus (HBV)-specific CD4 T cells in patients with chronic HBV infection is not clear. Thus, we aimed to elucidate this in patients with chronic infection, and those with hepatitis B flares.

METHODS

Through intracellular IFN-γ and TNF-α staining, HBV-specific CD4 T cells were analyzed in 68 patients with chronic HBV infection and alanine aminotransferase (ALT) <2x the upper limit of normal (ULN), and 28 patients with a hepatitis B flare. HBV-specific HLA-DRB10803/HLA-DRB11202-restricted CD4 T cell epitopes were identified.

RESULTS

TNF-α producing cells were the dominant population in patients' HBV-specific CD4 T cells. In patients with ALT <2xULN, both the frequency and the dominance of HBV-specific IFN-γ producing CD4 T cells increased sequentially in patients with elevated levels of viral clearance: HBV e antigen (HBeAg) positive, HBeAg negative, and HBV surface antigen (HBsAg) negative. In patients with a hepatitis B flare, the frequency of HBV core-specific TNF-α producing CD4 T cells was positively correlated with patients' ALT and total bilirubin levels, and the frequency of those cells changed in parallel with the severity of liver damage. Patients with HBeAg/HBsAg loss after flare showed higher frequency and dominance of HBV-specific IFN-γ producing CD4 T cells, compared to patients without HBeAg/HBsAg loss. Both the frequency and the dominance of HBV S-specific IFN-γ producing CD4 T cells were positively correlated with the decrease of HBsAg during flare. A differentiation process from TNF-α producing cells to IFN-γ producing cells in HBV-specific CD4 T cells was observed during flare. Eight and 9 HBV-derived peptides/pairs were identified as HLA-DRB10803 restricted epitopes and HLA-DRB11202 restricted epitopes, respectively.

CONCLUSIONS

HBV-specific TNF-α producing CD4 T cells are associated with liver damage, while HBV-specific IFN-γ producing CD4 T cells are associated with viral clearance in patients with chronic HBV infection.

LAY SUMMARY

TNF-α producing cells are the dominant population of hepatitis B virus (HBV)-specific CD4 T cells in patients with chronic HBV infection. This population of cells might contribute to the aggravation of liver damage in patients with a hepatitis B flare. HBV-specific IFN-γ producing CD4 T cells are associated with HBV viral clearance. Differentiation from HBV-specific TNF-α producing CD4 T cells into HBV-specific IFN-γ producing CD4 T cells might favor HBV viral clearance.

摘要

背景与目的

乙型肝炎病毒(HBV)特异性 CD4 T 细胞在慢性 HBV 感染患者中的作用尚不清楚。因此,我们旨在阐明慢性感染患者和乙型肝炎发作患者的 HBV 特异性 CD4 T 细胞情况。

方法

通过细胞内 IFN-γ 和 TNF-α 染色,分析了 68 例 ALT<2x 正常值上限(ULN)的慢性 HBV 感染患者和 28 例乙型肝炎发作患者的 HBV 特异性 CD4 T 细胞。鉴定了 HBV 特异性 HLA-DRB10803/HLA-DRB11202 限制性 CD4 T 细胞表位。

结果

TNF-α 产生细胞是患者 HBV 特异性 CD4 T 细胞中的主要群体。在 ALT<2xULN 的患者中,随着病毒清除水平的升高,HBV e 抗原(HBeAg)阳性、HBeAg 阴性和 HBV 表面抗原(HBsAg)阴性患者的 HBV 特异性 IFN-γ 产生 CD4 T 细胞的频率和优势依次增加。在乙型肝炎发作患者中,HBV 核心特异性 TNF-α 产生 CD4 T 细胞的频率与患者的 ALT 和总胆红素水平呈正相关,并且这些细胞的频率与肝损伤的严重程度平行变化。乙型肝炎发作后 HBeAg/ HBsAg 丢失的患者与无 HBeAg/ HBsAg 丢失的患者相比,HBV 特异性 IFN-γ 产生 CD4 T 细胞的频率和优势更高。HBV S 特异性 IFN-γ 产生 CD4 T 细胞的频率和优势与乙型肝炎发作期间 HBsAg 的下降呈正相关。在乙型肝炎发作期间,HBV 特异性 CD4 T 细胞中观察到从 TNF-α 产生细胞向 IFN-γ 产生细胞的分化过程。分别鉴定出 8 个和 9 个 HBV 衍生肽/对作为 HLA-DRB10803 限制性表位和 HLA-DRB11202 限制性表位。

结论

HBV 特异性 TNF-α 产生 CD4 T 细胞与慢性 HBV 感染患者的肝损伤有关,而 HBV 特异性 IFN-γ 产生 CD4 T 细胞与 HBV 病毒清除有关。

要点总结

在慢性 HBV 感染患者中,TNF-α 产生细胞是 HBV 特异性 CD4 T 细胞的主要群体。该细胞群可能导致乙型肝炎发作患者的肝损伤加重。HBV 特异性 IFN-γ 产生 CD4 T 细胞与 HBV 病毒清除有关。从 HBV 特异性 TNF-α 产生 CD4 T 细胞向 HBV 特异性 IFN-γ 产生 CD4 T 细胞的分化可能有利于 HBV 病毒的清除。

相似文献

1
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.HBV 特异性 CD4 T 细胞的 TNF-α/IFN-γ 谱与慢性 HBV 感染中的肝损伤和病毒清除相关。
J Hepatol. 2020 Jan;72(1):45-56. doi: 10.1016/j.jhep.2019.08.024. Epub 2019 Sep 6.
2
Association of cytokines with hepatitis B virus and its antigen.细胞因子与乙型肝炎病毒及其抗原的关联。
J Med Virol. 2020 Dec;92(12):3426-3435. doi: 10.1002/jmv.26301. Epub 2020 Aug 21.
3
Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.通过慢性和已治愈乙肝患者的γ干扰素反应评估代表乙肝核心抗原和表面抗原表位的20种肽的免疫原性
BMC Immunol. 2015 Nov 2;16:65. doi: 10.1186/s12865-015-0127-7.
4
[Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].[慢性乙肝病毒感染患者外周血T细胞中干扰素-γ和白细胞介素-4的变化]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Feb;32(2):240-4.
5
Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.未治疗的慢性乙型肝炎患者固有和适应性免疫反应细胞因子谱与临床病毒学特征的关系。
BMC Infect Dis. 2020 Jul 14;20(1):509. doi: 10.1186/s12879-020-05233-x.
6
Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.密切监测乙型肝炎表面抗原水平有助于在聚乙二醇干扰素治疗期间对爆发进行分类,并预测治疗反应。
Clin Infect Dis. 2013 Jan;56(1):100-5. doi: 10.1093/cid/cis859. Epub 2012 Oct 5.
7
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.联合 GS-4774 和替诺福韦治疗可改善慢性乙型肝炎患者的乙型肝炎病毒特异性 T 细胞应答。
Gastroenterology. 2019 Jul;157(1):227-241.e7. doi: 10.1053/j.gastro.2019.03.044. Epub 2019 Mar 28.
8
The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.慢性乙型肝炎病毒感染期间循环中不变自然杀伤T细胞的动态变化。
Hepatol Int. 2016 Jul;10(4):594-601. doi: 10.1007/s12072-015-9650-0. Epub 2016 Feb 26.
9
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.替比夫定治疗慢性乙型肝炎对细胞免疫应答的影响。
Antiviral Res. 2011 Jul;91(1):23-31. doi: 10.1016/j.antiviral.2011.04.008. Epub 2011 Apr 23.
10
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.乙型肝炎表面抗原对慢性乙型肝炎病毒感染患者病毒特异性和整体 T 细胞的影响。
Gastroenterology. 2020 Aug;159(2):652-664. doi: 10.1053/j.gastro.2020.04.019. Epub 2020 Apr 14.

引用本文的文献

1
HLA-DR⁺ Tumor Cells Show an Association with a Distinct Immune Microenvironment and CD8⁺ T-Cell Exhaustion in HBV-Associated Hepatocellular Carcinoma.HLA-DR⁺肿瘤细胞与乙肝相关肝细胞癌中独特的免疫微环境及CD8⁺T细胞耗竭相关。
Adv Sci (Weinh). 2025 Aug;12(30):e02979. doi: 10.1002/advs.202502979. Epub 2025 Jun 4.
2
Functional Cure for Hepatitis B Virus: Challenges and Achievements.乙肝病毒的功能性治愈:挑战与成就
Int J Mol Sci. 2025 Apr 11;26(8):3633. doi: 10.3390/ijms26083633.
3
Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy.
银屑病管理中的感染风险与疫苗接种:生物治疗的考量
Psoriasis (Auckl). 2025 Apr 11;15:127-144. doi: 10.2147/PTT.S510141. eCollection 2025.
4
Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue.聚乙二醇干扰素和核苷(酸)类似物治疗的低HBsAg定量慢性乙型肝炎患者基线时Th17和Treg细胞对HBsAg消失的预测价值
Liver Res. 2023 May 1;7(2):136-144. doi: 10.1016/j.livres.2023.04.002. eCollection 2023 Jun.
5
Probiotics and their metabolite spermidine enhance IFN-γCD4 T cell immunity to inhibit hepatitis B virus.益生菌及其代谢产物亚精胺可增强IFN-γ CD4 T细胞免疫,以抑制乙型肝炎病毒。
Cell Rep Med. 2024 Nov 19;5(11):101822. doi: 10.1016/j.xcrm.2024.101822. Epub 2024 Nov 12.
6
Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection.比较慢性 HBV 感染孕妇、产后和非孕妇的 HBV 特异性 T 细胞反应。
Front Immunol. 2024 Oct 10;15:1461767. doi: 10.3389/fimmu.2024.1461767. eCollection 2024.
7
Expression patterns of immune checkpoint proteins and -induced cytokines in chronic hepatitis B virus-infected and uninfected individuals: A cross-sectional study.慢性乙型肝炎病毒感染和未感染个体中免疫检查点蛋白及诱导细胞因子的表达模式:一项横断面研究。
Health Sci Rep. 2024 Jul 29;7(8):e2280. doi: 10.1002/hsr2.2280. eCollection 2024 Aug.
8
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction.MHC Ⅱ类转录激活因子在乙型肝炎病毒复制和病毒拮抗中的新作用
Clin Mol Hepatol. 2024 Jul;30(3):539-560. doi: 10.3350/cmh.2024.0060. Epub 2024 May 14.
9
Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer.CD4 T 淋巴细胞在稳态和癌症中的组织适应性。
Front Immunol. 2024 Apr 16;15:1379376. doi: 10.3389/fimmu.2024.1379376. eCollection 2024.
10
A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration.一种双域工程抗体,可有效抑制乙肝病毒并恢复免疫应答。
Adv Sci (Weinh). 2024 Apr;11(15):e2305316. doi: 10.1002/advs.202305316. Epub 2024 Feb 11.